Home > Media Report > Full Article

IASO Bio to Present at ASCO 2019

2019.05.20 | IASO,IASO Bio,IASO Biotherapeutics,IASO Biopharma,CT103A, CAR-T, cell therapy,dual-targeted CAR-T

Nanjing, China., April 09, 2019-IASO Biotherapeutics(IASO Bio), a clinical stage biotechnology company advancing the development of innovative therapies for cancer, today announced that IASO Bio will present clinical results (Abstract#8013) at American Society of Clinical Oncology Annual Meeting 2019 in Chicago Illionis on May 31-June 4.


For more information, please visit: